Want to track XVIVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XVIVO Perfusion AB (XVIVO) Statistics
Valuation metrics
Market Cap 6.74B
Enterprise value 6.56B
Trailing P/E (ttm) 76.16
Forward P/E -
PEG ratio -3.69
Price/Sales (ttm) 7.53
Price/Book (mrq) 3.06
Enterprise Value/Revenue 7.32
Enterprise Value/EBITDA 34.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 109.07K
Average volume (90 days) 74.08K
Price summary
52-Week low 160
52-Week high 322.4
Beta -
50-Day moving average 247.53
200-Day moving average 263.46
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 28.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.68
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.86%
Book value per share (mrq) 69.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
